Regional reportWhere is it happening?
Rest of Asia-Pacific
A fast-growing share of the published literature, led by India. We profile no organisations here yet.
India, Singapore, Taiwan and the rest of South, South-East and Central Asia.
AcceleratingConfidence high
Research trajectory, from scholarly works by author country: +24% a year over the latest three years, +11% in the three before. Data as of 8 Oct 2026.
Field snapshot
- 433
- scholarly works in 2025
- 12% of the world count; 11% in 2019
- 130
- PubMed papers in 2025
- held as individual records
- 4
- registered studies open now
- 1 with an implanted interface
- 0
- companies profiled
- none verified yet
- –
- disclosed in recorded rounds
- 0 rounds; a sample
- 0
- regulatory milestones recorded
- kept apart by type
Profiled companies at their headquarters, from the year each was founded.
0 marks on the companies layer in 2026, Rest of Asia-Pacific. Hover a mark, or use the list.
Marks are records, not decoration. Country marks sit at the centre of the country, not at an institution. Mark area follows the count, so a few large countries dominate; use the region zoom to read the rest. 3 profiled companies have not disclosed a location and are not placed. 36 countries with a small number of works have no position recorded and are not drawn. Clinical counts come from ClinicalTrials.gov and under-count studies outside the United States.
Research momentum
Authors in Rest of Asia-Pacific published 433 scholarly works on brain-computer interfaces in 2025, +48% on the year before. Over the latest three years output grew +24% a year, against +11% in the three years before; the world as a whole grew +23% a year.
| Year | Rest of Asia-Pacific |
|---|---|
| 2010 | 22 |
| 2011 | 27 |
| 2012 | 36 |
| 2013 | 61 |
| 2014 | 57 |
| 2015 | 72 |
| 2016 | 94 |
| 2017 | 90 |
| 2018 | 145 |
| 2019 | 166 |
| 2020 | 207 |
| 2021 | 236 |
| 2022 | 225 |
| 2023 | 261 |
| 2024 | 293 |
| 2025 | 433 |
| 2026 | 363 |
| Country | 2025 | Growth a year | Trajectory |
|---|---|---|---|
| India | 236 | +27% | Accelerating |
| Singapore | 43 | +13% | Accelerating |
| Pakistan | 41 | +29% | Slowing |
| Malaysia | 29 | +13% | Slowing |
| Taiwan | 23 | +1% | Slowing |
| Indonesia | 22 | +26% | Accelerating |
| Bangladesh | 12 | +20% | Accelerating |
| Vietnam | 10 | +49% | Emerging |
| Thailand | 9 | +14% | Slowing |
| Uzbekistan | 7 | +91% | Too little data |
| Kazakhstan | 6 | +26% | Accelerating |
Countries with at least five works in 2025. A work with authors in several countries counts once in each.
Companies and initiatives
We profile no organisation headquartered here yet. That is a statement about our coverage, not about the region: an organisation is added only once we have verified it from its own sources.
Clinical programmes
ClinicalTrials.gov lists 4 open studies with a site in Rest of Asia-Pacific, 1 of them involving an implanted interface. 2 studies started in 2025.
None of the studies we profile in detail has a site here.
Capital
No funding round is recorded for a company headquartered here. Public grants, which fund much of the work in several regions, are not tracked yet.
Regulatory environment
Regulation differs by country and we have not surveyed it. No implanted BCI study from this group of countries is profiled here.
Institutions in the corpus
No institution here is linked to a study or paper we profile.
Institutions appear here because a profiled study or paper names them. It is not a ranking, and many active groups are missing.
Latest developments
No dated milestone is recorded for this region yet.
Open questions and outlook
- Decoders that work out of the boxCan a BCI be useful on day one, for a new person, without hours of training?1–2 years · confidence moderate
- Neural interfaces as consumer productsDoes the first mass-market neural interface read the brain at all?1–2 years · confidence moderate
Forward-looking judgements by The BCI Briefing, with their reasoning on the Trends page. Uncertain by nature.
What we cannot see here
- We index publications and registered studies from these countries and profile no organisations. The coverage audit flags this as a gap.
Known to us, not yet verified
- Indian and Singaporean academic BCI groups
Leads are pointers for us to check: a study sponsor in a registry, a name in a report. They say nothing yet about what an organisation does, and none is counted anywhere on this site until it has a profile with sources.